[The efficacy of hepatotropic agent Remaxol in oncological patients with postoperative liver dysfunction].

The study of the efficiency and safety of the hepatotropic drug Remaxol in oncological patients with minimal, subclinical manifestations of liver dysfunction in the postoperative period was performed. It is shown that using of Remaxolcontributes to leveling the biochemical liver dysfunction: decrease of the concentration of total bilirubin, a decrease serum activity of lactate dehydrogenase, alanine aminotransferase, aspartate aminotransferase, and alkaline phosphatase. The unwanted effects of Remaxol were not identified.

[Methods of optimizing and objective criteria for evaluating the efficacy of chemo-surgical treatment of malignant epithelial tumors of the ovaries].

In a group of 811 patients with epithelial malignancies of the ovaries, the diagnostic and therapeutic procedures used were either standard or they involved elements of optimization based on certain objective criteria. The reliability of diagnosis and treatment efficacy in the two subgroups were compared. Stage I-II tumors made up 37.

[Reasons for repeat operations in patients with tumors of the ovaries].

The paper deals with the analysis of reasons for repeat surgery in 242 patients who had undergone sparing operations on the inner genitals for tumors of various origin. In 121, sparing surgery had been performed for benign tumor of the ovary whereas in 70--for underdiagnosed malignancy. At the time of the first operation, 55 patients were more than 45 years of age; 33 of them subsequently died of advanced ovarian cancer.